S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable
S&P 500   4,554.89
DOW   35,416.98
QQQ   390.19
Alibaba is down more than 10% since earnings, now what?
Secure your stake in the Smart Home industry. (Ad)
5 stocks for the Christmas wishlist: Hoping for a pullback
Teva Pharma is the way to play the re-rise of generic drugs
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Lemonade nears breakout, short interest surges, analysts bearish
ULTA stock is setting up to swing for the fences
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Get ready for Christmas shopping-sprees with these 2 winners
Li Auto smashes estimates proving EVs can be profitable

C&C Group Share Price, News & Analysis (LON:CCR)

GBX 138.20
-2.00 (-1.43%)
(As of 11/28/2023 ET)
Compare
Today's Range
136.20
140.40
50-Day Range
132
145.20
52-Week Range
120.40
188
Volume
242,544 shs
Average Volume
834,039 shs
Market Capitalization
£543.10 million
P/E Ratio
1,151.67
Dividend Yield
3.62%
Price Target
GBX 200

C&C Group MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
44.7% Upside
GBX 200 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
£8.45 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.31 out of 5 stars


CCR stock logo

About C&C Group Stock (LON:CCR)

C&C Group plc manufactures, markets, and distributes beer, cider, wine, spirits, and soft drinks in the Republic of Ireland, Great Britain, and internationally. The company offers its products primarily under the Tennent's, Bulmers, Magners, Orchard Pig, Heverlee, 5 Lamps, Fête, Blackthorn, Seven Summits, Dowd's Lane, Chaplin & Cork's, Celedonia Best, and Addlestones brand name. It also distributes third party branded beers, wines, spirits, cider, and soft drinks. The company was founded in 1935 and is headquartered in Dublin, the Republic of Ireland.

CCR Stock Price History

CCR Stock News Headlines

Why C&C Group plc (LON:CCR) Could Be Worth Watching
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
C&C Group PLC CCR
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Statement re FY2024 H1 pre-close Trading Statement
CCR.L - C&C Group plc
Statement re Trading Update & Directorate Changes
Pre-close Trading Statement
What Is C&C Group plc's (LON:CCR) Share Price Doing?
See More Headlines
Receive CCR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for C&C Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 12/1 Dividend
11/09/2023
Today
11/28/2023
Dividend Payable
12/01/2023

Industry, Sector and Symbol

Industry
Beverages - Brewers
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,897
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 200
High Stock Price Target
GBX 200
Low Stock Price Target
GBX 200
Potential Upside/Downside
+44.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
£27.20 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.66 billion
Cash Flow
GBX 26.18 per share
Book Value
GBX 190 per share

Miscellaneous

Free Float
N/A
Market Cap
£543.10 million
Optionable
Not Optionable
Beta
1.32
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Patrick McMahon (Age 43)
    Group CEO, Group CFO & Executive Director
    Comp: $652.1k
  • Mr. Mark Chilton (Age 60)
    Company Secretary & Group General Counsel
  • Mr. Ralph Graham Findlay FCA (Age 62)
    O.B.E., Executive Chairman
    Comp: $162.37k
  • Joe Thompson
    Head of Investor Relations
  • Sarah Riley
    Group Director of Human Resources
  • Mr. Joris Brams (Age 54)
    Managing Director of International Division
    Comp: $1.05M
  • Mr. Michael Saunders
    Chief Executive Officer of Bibendum
  • Mr. Patrick Morrissey
    Group Operations Director
  • James Scott
    Group Insight Director
  • Mr. Steve Thomson
    Matthew Clark Wholesale-Chairman














CCR Stock Analysis - Frequently Asked Questions

Should I buy or sell C&C Group stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for C&C Group in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CCR shares.
View CCR analyst ratings
or view top-rated stocks.

What is C&C Group's stock price target for 2024?

2 brokerages have issued twelve-month price objectives for C&C Group's shares. Their CCR share price targets range from GBX 200 to GBX 200. On average, they predict the company's share price to reach GBX 200 in the next twelve months. This suggests a possible upside of 44.7% from the stock's current price.
View analysts price targets for CCR
or view top-rated stocks among Wall Street analysts.

How have CCR shares performed in 2023?

C&C Group's stock was trading at GBX 175.30 at the start of the year. Since then, CCR stock has decreased by 21.2% and is now trading at GBX 138.20.
View the best growth stocks for 2023 here
.

How often does C&C Group pay dividends? What is the dividend yield for C&C Group?

C&C Group declared a dividend on Thursday, October 26th. Investors of record on Thursday, November 9th will be given a dividend of GBX 0.02 per share on Friday, December 1st. This represents a yield of 1.18%. The ex-dividend date of this dividend is Thursday, November 9th. The official announcement can be accessed at this link.
Read our dividend analysis for CCR
.

Is C&C Group a good dividend stock?

C&C Group (LON:CCR) pays an annual dividend of GBX 5 per share and currently has a dividend yield of 3.49%. The dividend payout ratio is 4,166.67%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CCR.

What other stocks do shareholders of C&C Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other C&C Group investors own include Taylor Wimpey (TW), Bellway (BWY), Rotork (ROR), Tesco (TSCO), Karuna Therapeutics (KRTX), KBR (KBR), Ibstock (IBST), Ithaca Energy (IAE), The Hain Celestial Group (HAIN) and Diageo (DGE).

How do I buy shares of C&C Group?

Shares of CCR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:CCR) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -